StockNews.AI
CHE
StockNews.AI
186 days

Chemed Corporation Declares Quarterly Dividend of 50 Cents

1. Chemed announced a quarterly dividend of 50 cents per share. 2. This is Chemed's 215th consecutive quarterly dividend payout. 3. The dividend is payable on March 14, 2025, for record shareholders. 4. Chemed operates VITAS Healthcare and Roto-Rooter, both leaders in their sectors. 5. Forward-looking statements carry risks that could affect Chemed’s future results.

5m saved
Insight
Article

FAQ

Why Bullish?

Consistent dividends strengthen investor confidence, boosting CHE's attractiveness as an investment.

How important is it?

Dividend consistency indicates financial health, impacting market perception positively.

Why Short Term?

The immediate dividend announcement is expected to positively influence CHE's stock in the short term.

Related Companies

Chemed Corporation Declares Quarterly Dividend of 50 Cents

CINCINNATI--( )--Chemed Corporation (NYSE:CHE) announced today that the Board of Directors has declared a quarterly cash dividend of 50-cents per share on the Company’s capital stock, payable on March 14, 2025, to shareholders of record as of February 24, 2025. This is equal to the dividend paid in December 2024. This represents the 215th consecutive quarterly dividend paid by Chemed in its 53 years as a public company.

Listed on the New York Stock Exchange and headquartered in Cincinnati, Ohio, Chemed Corporation (www.chemed.com) operates two wholly owned subsidiaries: VITAS Healthcare and Roto-Rooter. VITAS is the nation's largest provider of end-of-life hospice care and Roto-Rooter is the nation’s leading provider of plumbing and drain cleaning services.

Statements in this press release or in other Chemed communications may relate to future events or Chemed's future performance. Such statements are forward-looking statements and are based on present information Chemed has related to its existing business circumstances. Investors are cautioned that such forward-looking statements are subject to inherent risk that actual results may differ materially from such forward-looking statements. Further, investors are cautioned that Chemed does not assume any obligation to update forward-looking statements based on unanticipated events or changed expectations.

Contacts

Michael D. Witzeman
(513) 762-6714

Related News